Home » Newsletters » BioWorld

BioWorld

April 5, 1993

View Archived Issues

PHILP TO MANUFACTURE IGENE'S SALMON PIGMENT

CONGRESSMAN OVERSTATED CEREDASE PROFITS

GENESYS REVIEWS ANTISENSE AIDS DRUG

COLLINS TO HEAD GENOME PROJECT

LA JOLLA DEVELOPS LUPUS TREATMENT

EUROPEAN PATENT DISCLOSURES

APPOINTMENTS AND ADVANCEMENTS

INNOVET RAISES $5 MILLION

HYGEIA IND FOR MAB TO TREAT CANCER

USING LIGHT TO PREVENT SCARRING

BRITISH BIO STARTS AIDS TRIAL IN EUROPE

NO SURPRISE THAT AZT ALONE IS INADEQUATE

FDA ASKS ALTEON TO AMEND PROTOCOLS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...